NetworkNewsBreaks – Nabis Holdings Inc. (CSE: NA
Post# of 31
(Total Views: 155)
Posted On: 06/25/2019 3:33:05 PM
NetworkNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Acquires 49% Interest in Cannova Medical
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced completion of the purchase of 2,260,500 common shares of Cannova Medical Ltd., a provider of innovative solutions for cannabis consumption. The purchase represents Nabis Holdings’ 49% interest in Cannova with the option to acquire the remaining 51% interest. Based in Israel, Cannova is developing an alternative method for cannabis consumption in the form of a sublingual strip that allows more effective control of dosage quantities. “Our goal for strategic investments at Nabis is to enter multiple aspects of the cannabis sector including related technology,” Nabis CEO and Director Shay Shnet said in the news release. “The Cannova team is focused on developing innovative solutions addressing an industry wide concern to have the ability to better measure cannabis consumption. We are thrilled to have closed our 49% interest acquisition enabling the Cannova team to bring this disruptive technology to market at an increased pace.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced completion of the purchase of 2,260,500 common shares of Cannova Medical Ltd., a provider of innovative solutions for cannabis consumption. The purchase represents Nabis Holdings’ 49% interest in Cannova with the option to acquire the remaining 51% interest. Based in Israel, Cannova is developing an alternative method for cannabis consumption in the form of a sublingual strip that allows more effective control of dosage quantities. “Our goal for strategic investments at Nabis is to enter multiple aspects of the cannabis sector including related technology,” Nabis CEO and Director Shay Shnet said in the news release. “The Cannova team is focused on developing innovative solutions addressing an industry wide concern to have the ability to better measure cannabis consumption. We are thrilled to have closed our 49% interest acquisition enabling the Cannova team to bring this disruptive technology to market at an increased pace.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)